Alon Gurfinkel
Lawyers

Filters
AsiaInfo Technologies Limited HK$865.3 Million (US$110.6 Million) Initial Public Offering
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S of…
SoftBank IPO
Davis Polk advised the joint global coordinators in connection with the initial public offering of 1,603,693,700 shares of common stock of SoftBank Corp. The shares were sold by SoftBank…
Ahold Delhaize Cash Tender Offer
Davis Polk advised the dealer managers in connection with a cash tender offer by Koninklijke Ahold Delhaize N.V. for up to $350 million principal amount of its 5.70% senior notes due…
Tencent Music Entertainment Group $1.1 billion IPO and NYSE listing
Davis Polk advised Tencent Music Entertainment Group on its SEC-registered initial public offering of 82,000,000 American Depositary Shares, consisting of 41,029,829 ADSs sold by Tencent…
Baidu $250 Million Notes Offering
Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of $250 million 4.375% notes due 2024 (to be consolidated and form a single series with the $600…
Logan Property Holdings Company $370 Million Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a $370 million Regulation S only offering by Logan Property Holdings Company Limited of its 8.75% senior notes due 2020…
Davis Polk Advises Notre Dame Intermédica on Its R$2.7 Billion Equity Offering
Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of Notre Dame…
MOGU Inc. Initial Public Offering and NYSE Listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by MOGU Inc. of 4,750,000 American Depositary Shares, each representing 25 Class A ordinary shares,…
Davis Polk Advises Mereo BioPharma Group plc on Its Combination with OncoMed Pharmaceuticals, Inc.
Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction, which is subject to customary closing conditions and the approval of…
FTI Consulting, Inc. $550 Million Amended and Restated Revolving Credit Facility
Davis Polk advised the administrative agent and the joint lead arrangers in connection with the amendment and restatement of a $550 million senior secured revolving credit facility for FTI…